Back to Search Start Over

P47.10 Neoadjuvant Osimertinib in EGFR-Mutant Stage IIIA/B NSCLC - A Phase 2 Open-Label Pilot Study.

Authors :
Kian, W.
Roisman, L.C.
Chernomordikov, E.
Allen, A.M.
Corn, B.
Dudnik, E.
Keren, S.
Zemel, M.
Lavrenkov, K.
Peled, N.
Source :
Journal of Thoracic Oncology; 2021 Supplement, Vol. 16 Issue 10, pS1100-S1100, 1p
Publication Year :
2021

Details

Language :
English
ISSN :
15560864
Volume :
16
Issue :
10
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
153097390
Full Text :
https://doi.org/10.1016/j.jtho.2021.08.503